2020
DOI: 10.21203/rs.2.10177/v5
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients

Abstract: Background : Sex is recognized as a significant determinant of outcome among glioblastoma patients, but the relative prognostic importance of glioblastoma features has not been thoroughly explored for sex differences. Methods : Combining multi-modal MR images, biomathematical models, and patient clinical information, this investigation assesses which pretreatment variables have a sex-specific impact on the survival of glioblastoma patients (299 males and 195 females). Results : Among males, tumor (T1Gd) radius… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 41 publications
(29 reference statements)
0
1
0
Order By: Relevance
“…In concordance, mutant IDH1/2 inhibitors, which are currently in clinical trials for multiple cancers [218] might exhibit sexspecific effects. In glioblastoma, a sex-specific effect of IDH mutations on overall survival has been evaluated in multiple publications [56,59,219]; however, the findings are inconsistent and further study will be required to define how interaction between IDH1 mutation and patient sex impacts on survival.…”
Section: Implications For Targeting Metabolismmentioning
confidence: 99%
“…In concordance, mutant IDH1/2 inhibitors, which are currently in clinical trials for multiple cancers [218] might exhibit sexspecific effects. In glioblastoma, a sex-specific effect of IDH mutations on overall survival has been evaluated in multiple publications [56,59,219]; however, the findings are inconsistent and further study will be required to define how interaction between IDH1 mutation and patient sex impacts on survival.…”
Section: Implications For Targeting Metabolismmentioning
confidence: 99%